MedinCell Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Christophe Douat
Chief executive officer
€781.5k
Total compensation
| CEO salary percentage | 38.0% |
| CEO tenure | 10.3yrs |
| CEO ownership | n/a |
| Management average tenure | 4.2yrs |
| Board average tenure | less than a year |
Recent management updates
Recent updates
MedinCell S.A. (EPA:MEDCL) Analysts Are More Bearish Than They Used To Be
Jul 05
Revenues Tell The Story For MedinCell S.A. (EPA:MEDCL) As Its Stock Soars 30%
Apr 26Market Participants Recognise MedinCell S.A.'s (EPA:MEDCL) Revenues Pushing Shares 26% Higher
Jan 09The MedinCell (EPA:MEDCL) Share Price Is Up 75% And Shareholders Are Holding On
Mar 02Is MedinCell S.A. (EPA:MEDCL) Popular Amongst Insiders?
Jan 08CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | €782k | €297k | -€25m |
| Dec 31 2023 | n/a | n/a | -€26m |
| Sep 30 2023 | n/a | n/a | -€26m |
| Jun 30 2023 | n/a | n/a | -€29m |
| Mar 31 2023 | €522k | €267k | -€32m |
| Dec 31 2022 | n/a | n/a | -€29m |
| Sep 30 2022 | n/a | n/a | -€27m |
| Jun 30 2022 | n/a | n/a | -€26m |
| Mar 31 2022 | €329k | €258k | -€25m |
| Dec 31 2021 | n/a | n/a | -€22m |
| Sep 30 2021 | n/a | n/a | -€20m |
| Jun 30 2021 | n/a | n/a | -€19m |
| Mar 31 2021 | €336k | €235k | -€19m |
| Dec 31 2020 | n/a | n/a | -€22m |
| Sep 30 2020 | n/a | n/a | -€26m |
| Jun 30 2020 | n/a | n/a | -€25m |
| Mar 31 2020 | €301k | €232k | -€24m |
| Dec 31 2019 | n/a | n/a | -€21m |
| Sep 30 2019 | n/a | n/a | -€19m |
| Jun 30 2019 | n/a | n/a | -€19m |
| Mar 31 2019 | €244k | €192k | -€20m |
| Dec 31 2018 | n/a | n/a | -€17m |
| Sep 30 2018 | n/a | n/a | -€15m |
| Jun 30 2018 | n/a | n/a | -€12m |
| Mar 31 2018 | €175k | €149k | -€10m |
Compensation vs Market: Christophe's total compensation ($USD822.75K) is above average for companies of similar size in the French market ($USD537.06K).
Compensation vs Earnings: Christophe's compensation has increased whilst the company is unprofitable.
CEO
Christophe Douat (58 yo)
10.3yrs
Tenure
€781,528
Compensation
Mr. Christophe Douat has been the Chief Executive Officer of MedinCell S.A and serves as its Director since September 12, 2024. He served as Chairman of the Management Board at MedinCell S.A until Septembe...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer & Director | 10.3yrs | €781.53k | no data | |
| Chief People Officer & Member of the Management Board | 4.6yrs | €383.09k | no data | |
| Chief Financial Officer | 1.2yrs | no data | no data | |
| Head of Legal | 3.8yrs | no data | no data | |
| Head of Communications | no data | no data | no data | |
| Head of Research & Development | no data | no data | no data | |
| Chief Business Officer | 2.8yrs | no data | no data | |
| Head of Alliance & Project Management | 5.4yrs | no data | no data | |
| Head of Global Health Development | 8yrs | no data | no data | |
| Chief Medical Officer | 2.6yrs | no data | no data | |
| Head of Pharmaceutical Operations | no data | no data | no data | |
| Senior Communications Officer | no data | no data | no data |
4.2yrs
Average Tenure
Experienced Management: MEDCL's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer & Director | less than a year | €781.53k | no data | |
| Director | less than a year | €25.00k | no data | |
| Director | less than a year | €26.50k | no data | |
| Chairman of the Board | less than a year | €28.00k | no data | |
| Director | less than a year | €25.00k | no data | |
| Censor | no data | no data | no data | |
| Director | less than a year | €21.00k | no data |
0.2yrs
Average Tenure
58yo
Average Age
Experienced Board: MEDCL's board of directors are not considered experienced ( 0.2 years average tenure), which suggests a new board.